Pharmacotherapy of tobacco dependence

Medical Clinics of North America

Volumn 88, Issue 6, 2004, Pages 1517-1534

  Talwar, Arunabh ^a,b   Jain, Mukesh ^c   Vijayan, V K ^d  

^a Div Pulmon and Critical Care Med   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONIDINE; HYDROCORTISONE; NICOTINE; NICOTINE GUM; NON PRESCRIPTION DRUG; NORTRIPTYLINE; TRIAMCINOLONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY; APPETITE DISORDER; BEHAVIOR THERAPY; BRADYCARDIA; CLINICAL PRACTICE; CLINICAL TRIAL; CONSTIPATION; COUGHING; CREAM; DEPRESSION; DIZZINESS; DROWSINESS; DRUG CONTRAINDICATION; DRUG HYPERSENSITIVITY; DYSPEPSIA; DYSPHORIA; FRUSTRATION; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEARTBURN; HICCUP; HUMAN; INSOMNIA; IRRITABILITY; MENTAL CONCENTRATION; MOUTH LESION; MYOFASCIAL PAIN; NERVOUSNESS; NEUROBIOLOGY; NICOTINE REPLACEMENT THERAPY; NOSE ALLERGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RESPIRATORY TRACT DISEASE; REVIEW; RHINITIS; SEDATION; SIDE EFFECT; SKIN MANIFESTATION; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT INDICATION; TREATMENT OUTCOME; URINE RETENTION; VISUAL IMPAIRMENT; WEIGHT GAIN; WITHDRAWAL SYNDROME; XEROSTOMIA;

ADRENERGIC ALPHA-AGONISTS; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; CLONIDINE; FEMALE; HUMANS; MALE; NICOTINE; NICOTINIC AGONISTS; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; UNITED STATES;

EID: 4644305102     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2004.07.011     Document Type: Review

References (52)

1. B. Karnath Smoking cessation Am J Med 112 2002 399 405
2. K. Fagerstrom The epidemiology of smoking: health consequences and benefits of cessation Drugs 62 Suppl 2 2002 1 9
3. R. Doll, and R. Peto Mortality in relation to smoking: 20 years' observations on male British doctors BMJ 2 1976 1525 1536
4. M.C. Fiore, D.E. McCarthy, T.C. Jackson, M.E. Zehner, D.E. Jorenby, and M. Mielke Integrating smoking cessation treatment into primary care: an effectiveness study Prev Med 38 2004 412 420
5. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives A clinical practice guideline for treating tobacco use and dependence: a US Public Health Service report JAMA 283 2000 3244 3254
6. M.C. Fiore, W.C. Bailey, and S.J. Cohen Treating tobacco use and dependence: clinical practice guideline 2000 US Department of Health and Human Services, Public Health Service Rockville (MD)
7. H.P. Stauffer, and H. Riedwyl Interaction and pH dependence of effects of nicotine and carbon monoxide in cigarette smoke inhalation experiments with rats Agents Actions 7 1977 579 588
8. F.M. Zhou, Y. Liang, and J.A. Dani Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum Nat Neurosci 4 2001 1224 1229
9. F.E. Pontieri, G. Tanda, F. Orzi, and G. Di Chiara Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs Nature 382 1996 255 257
10. T.F. Heatherton, L.T. Kozlowski, R.C. Frecker, and K.O. Fagerstrom The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire Br J Addict 86 1991 1119 1127
11. J. Foulds, M. Burke, M. Steinberg, J.M. Williams, and D.M. Ziedonis Advances in pharmacotherapy for tobacco dependence Expert Opin Emerg Drugs 9 2004 39 53
12. C. Silagy, T. Lancaster, L. Stead, D. Mant, and G. Fowler Nicotine replacement therapy for smoking cessation Cochrane Database Syst Rev 2001 CD000146
13. S. Shiffman, W.G. Shadel, R. Niaura, M.A. Khayrallah, D.E. Jorenby, and C.F. Ryan Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving Psychopharmacology (Berl) 166 2003 343 350
14. J.R. Hughes, M.G. Goldstein, R.D. Hurt, and S. Shiffman Recent advances in the pharmacotherapy of smoking JAMA 281 1999 72 76
15. J. Foulds, M.A. Russell, M.J. Jarvis, and C. Feyerabend Nicotine absorption and dependence in unlicensed lozenges available over the counter Addiction 93 1998 1427 1431
16. R. West, P. Hajek, F. Nilsson, J. Foulds, S. May, and A. Meadows Individual differences in preferences for and responses to four nicotine replacement products Psychopharmacology (Berl) 153 2001 225 230
17. P. Hajek, R. West, J. Foulds, F. Nilsson, S. Burrows, and A. Meadow Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler Arch Intern Med 159 1999 2033 2038
18. J.R. Hughes, S. Shiffman, P. Callas, and J. Zhang A meta-analysis of the efficacy of over-the-counter nicotine replacement Tob Control 12 2003 21 27
19. N.G. Schneider, R. Olmstead, F. Nilsson, F.V. Mody, M. Franzon, and K. Doan Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial Addiction 91 1996 1293 1306
20. S. Shiffman, C.M. Dresler, P. Hajek, S.J. Gilburt, D.A. Targett, and K.R. Strahs Efficacy of a nicotine lozenge for smoking cessation Arch Intern Med 162 2002 1267 1276
21. D. Hoffmann, and M.V. Djordjevic Chemical composition and carcinogenicity of smokeless tobacco Adv Dent Res 11 1997 322 329
22. N.L. Benowitz, and S.G. Gourlay Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy J Am Coll Cardiol 29 1997 1422 1431
23. E.C. Keeley, M.J. Pirwitz, C. Landau, R.A. Lange, L.D. Hillis, and E.H. Foerster Intranasal nicotine spray does not augment the adverse effects of cigarette smoking on myocardial oxygen demand or coronary arterial dimensions Am J Med 101 1996 357 363
24. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease Nicotine replacement therapy for patients with coronary artery disease Arch Intern Med 154 1994 989 995
25. N.L. Benowitz Nicotine replacement therapy. What has been accomplished, can we do better? Drugs 45 1993 157 170
26. D. Dempsey, P. Jacob III, and N.L. Benowitz Accelerated metabolism of nicotine and cotinine in pregnant smokers J Pharmacol Exp Ther 301 2002 594 598
27. K. Wisborg, T.B. Henriksen, L.B. Jespersen, and N.J. Secher Nicotine patches for pregnant smokers: a randomized controlled study Obstet Gynecol 96 2000 967 971
28. A. Molyneux Nicotine replacement therapy BMJ 328 2004 454 456
29. C.T. Sweeney, R.V. Fant, K.O. Fagerstrom, J.F. McGovern, and J.E. Henningfield Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability CNS Drugs 15 2001 453 467
30. M. Kornitzer, M. Boutsen, M. Dramaix, J. Thijs, and G. Gustavsson Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial Prev Med 24 1995 41 47
31. A. Bohadana, F. Nilsson, T. Rasmussen, and Y. Martinet Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial Arch Intern Med 160 2000 3128 3134
32. J.D. Kassel, L.R. Stroud, and C.A. Paronis Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking Psychol Bull 129 2003 270 304
33. J.A. Ascher, J.O. Cole, J.N. Colin, J.P. Feighner, R.M. Ferris, and H.C. Fibiger Bupropion: a review of its mechanism of antidepressant activity J Clin Psychiatry 56 1995 395 401
34. A.S. Rauhut, N. Neugebauer, L.P. Dwoskin, and M.T. Bardo Effect of bupropion on nicotine self-administration in rats Psychopharmacology (Berl) 169 2003 1 9
35. J.E. Slemmer, B.R. Martin, and M.I. Damaj Bupropion is a nicotinic antagonist J Pharmacol Exp Ther 295 2000 321 327
36. R.D. Hurt, D.P. Sachs, E.D. Glover, K.P. Offord, J.A. Johnston, and L.C. Dale A comparison of sustained-release bupropion and placebo for smoking cessation N Engl J Med 337 1997 1195 1202
37. J.T. Hays, R.D. Hurt, N.A. Rigotti, R. Niaura, D. Gonzales, and M.J. Durcan Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial Ann Intern Med 135 2001 423 433
38. J.T. Hays, and J.O. Ebbert Bupropion sustained release for treatment of tobacco dependence Mayo Clin Proc 78 2003 1020 1024 [quiz 4]
39. J.R. Hughes, L.F. Stead, and T. Lancaster Antidepressants for smoking cessation Cochrane Database Syst Rev 2003 CD000031
40. T. Coleman Smoking cessation: integrating recent advances into clinical practice Thorax 56 2001 579 582
41. J. Martinez-Raga, F. Keaney, G. Sutherland, B. Perez-Galvez, and J. Strang Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile Addict Biol 8 2003 13 21
42. D.E. Jorenby, S.J. Leischow, M.A. Nides, S.I. Rennard, J.A. Johnston, and A.R. Hughes A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation N Engl J Med 340 1999 685 691
43. T.P. George, J.C. Vessicchio, A. Termine, P.I. Jatlow, T.R. Kosten, and S.S. O'Malley A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation Biol Psychiatry 53 2003 136 143
44. N.B. Edwards, J.K. Murphy, A.D. Downs, B.J. Ackerman, and T.L. Rosenthal Doxepin as an adjunct to smoking cessation: a double-blind pilot study Am J Psychiatry 146 1989 373 376
45. S.G. Gourlay, L.F. Stead, and N.L. Benowitz Clonidine for smoking cessation Cochrane Database Syst Rev 2000 CD000058
46. S.G. Gourlay, and N.L. Benowitz Is clonidine an effective smoking cessation therapy? Drugs 50 1995 197 207
47. Anthenelli RMDJ. Effects of rimonabant in the reduction of major cardiovascular risk factors: results from the STRATUS_US trial (Smoking Cessation in Smokers Motivated to Quit). Presented at the American College of Cardiology 53rd Annual Scientific Meeting. New Orleans, March 9, 2004.
48. S.R. Laviolette, and D. van der Kooy The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour Nat Rev Neurosci 5 2004 55 65
49. C.R. Park, and D.L. Munday Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy Int J Pharm 237 2002 215 226
50. S.F.R. Shiffman, R.V. Fant, J.G. Gitchell, E.J. Cone, J.E. Henningfield, and K.O. Fagerstrom Nicotine delivery systems: how far has technology come? American Journal of Drug Delivery 1 2003 112 124
51. E.C. Westman, K.F. Tomlin, C.E. Perkins, and J.E. Rose Oral nicotine solution for smoking cessation: a pilot tolerability study Nicotine Tob Res 3 2001 391 396
52. Lindmayer KHG, Horwith G, Fattom A, Naso R, Fuller S, Muenz L, et al. Results of phase I double-blinded controlled safety and immunogenicity trial of NICVAX, a nicotine conjugated vaccine. Presented at the Society for Research on Nicotine and Tobacco, 9th Annual Meeting. New Orleans, February 19-22, 2003.